Mandate

Vinge advises AcadeMedia in connection with the public offer from Providence

April 22, 2010

Vinge advises AcadeMedia AB (publ) ("AcadeMedia") in connection with the public offer from Providence for all outstanding shares in AcadeMedia, which was announced on 22 April 2010. Providence offers SEK 170 for each share in AcadeMedia and the total value of the offer amounts to SEK 2,050 million. Providence has received undertakings to accept the offer from some of the major shareholders in AcadeMedia, who together own shares corresponding to approximately 17.4 per cent of all outstanding shares and votes in AcadeMedia. The offer is recommended by the bid committee of AcadeMedia which has been appointed in connection with the offer.
 
AcadeMedia is the largest education company in Sweden. AcadeMedia currently has approximately 45,000 students and course attendants, in excess of 100 schools and around 2,500 employees with operations within the entire Swedish education area: pre-, compulsory-, and upper secondary schools and within adult education. The operations are conducted through independent schools and companies such as Vittra, NTI, Rytmus, IT-Gymnasiet, Ljud & Bildskolan and Mikael Elias Teoretiska Gymnasium. AcadeMedia is listed on NASDAQ OMX Stockholm, Small Cap.

Vinge's team consists of Göran Nyström and Dain Nevonen. Erik Sjöman and Jesper Schönbeck have advised in certain matters related to capital markets law.
 

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026